Chinese scientists have found a common hypertension drug could prove potent in treating a rare but highly invasive brain ...

Objective: The aim of this study was to compare the antihypertensive efficacy and tolerability of the calcium channel antagonist amlodipine besylate versus the angiotensin II type 1 receptor ...

Both therapeutic regimens (amlodipine besylate and candesartan cilexetil) were very effective in lowering office BP after 12 weeks of treatment. There was a trend towards better self-measured BP ...

The US Court of Appeals for the Federal Circuit has reversed the New Jersey District Court's dismissal of Pfizer's patent infringement action against Dr Reddy's Laboratories' generic version of ...